Takeda

Showing 15 posts of 249 posts found.

Takeda image

Takeda expands in Singapore

March 3, 2015
Manufacturing and Production Singapore, Takeda, biopolis, emerging markets, vaccines

Japanese pharma giant Takeda has set up new Singapore offices in the Biopolis biomedical complex with the aim of expanding …

Takeda image

Takeda acquires Turkish firm Neutec

February 24, 2015
Sales and Marketing Takeda, Turkey, gastroenterology, neutec, respiratory, turkish

Takeda has signed an agreement to acquire one of Turkey’s leading pharma firms Neutec in a $120 million deal. The …

Takeda image

Takeda trial hits late-stage buffers

February 17, 2015
Research and Development, Sales and Marketing AMG 706, Japan, NSCLC, Takeda, lung cancer, motesanib

Takeda is to scrap an advanced trial of an investigational drug after it failed to show any benefit in survival …

Takeda image

Takeda scraps vaccine trial in Phase II

February 2, 2015
Research and Development, Sales and Marketing Diptheria-Tetanus-acellular Pertussis (DTaP) and Sabin inactivated poliovirus vaccine (sIPV), Rajeev Venkayya, TAK-361S, Takeda

Takeda has announced it is abandoning the development of a vaccine in Japan that was in Phase II clinical trials.TAK-361S, …

Rajeev Venkayya, president of Takeda Vaccines image

Interview: Rajeev Venkayya, president of Takeda Vaccine

January 19, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bush, Ebola, Gates, Rajeev Venkayya, Takeda, brett wells, vaccines

 Rajeev Venkayya is the president of the global vaccine business unit at Takeda Pharmaceuticals. He has served as special assistant …

Takeda image

Takeda trials Teva Parkinson’s drug in Japan

January 9, 2015
Sales and Marketing Azilect, CHMP, Copaxone, Parkinson's, Takeda, rasagiline

Takeda has begun late stage trials for Teva’s Parkinson’s disease drug Azilect in Japan, with the hopes of bringing the …

Entyvio image

NICE rejects Takeda Crohn’s disease drug

December 23, 2014
Sales and Marketing Crohn’s disease, Entyvio, NHS, NICE, Takeda, crohn's disease, vedolizumab

Takeda has seen its treatment for people with Crohn’s disease Entyvio rejected by NICE in an initial appraisal. The healthcare …

andrew_plump_takeda

Takeda takes senior head from Sanofi

December 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Takeda, andrew plump

Dr Andrew Plump will be joining Takeda in February from Sanofi to lead its global R&D operations as chief medical …

GSK image

GSK Ebola vaccine gets EU support

December 17, 2014
Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …

Takeda image

Takeda eyes new drug licences following positive blood cancer studies

December 11, 2014
Research and Development, Sales and Marketing Adcetris, Takeda, Velcade, ash, bortezomib, brentuximab vedotin, hematology

Takeda is bringing its biotech arm in-house to create a global oncology business unit, which it says will drive forward …

Actos image

Analysis finds no Actos bladder cancer link

December 8, 2014
Sales and Marketing Actos, Cancer, Takeda, bladder, lilly, pioglitazone, type 2

A large-scale analysis of patient data has found that pioglitazone, the diabetes drug that is the subject of ongoing safety …

GSK image

GSK Ebola vaccine ‘promising’ in early trials

November 27, 2014
Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines

The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …

Takeda image

GE and Takeda make liver pact

November 13, 2014
Research and Development, Sales and Marketing GE Healthcare, Japan, Takeda, US, liver, nafld, nash

GE Healthcare and Takeda Pharmaceutical have joined forces to develop treatments which target liver conditions including non-alcoholic fatty liver disease …

marc_princen-

Takeda hires Merck senior head as president

November 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, marc princen

Marc Princen has joined Takeda Pharmaceuticals from Merck and is to serve as its corporate officer and president of the …

Actos image

Takeda and Lilly get Actos trial reprieve

October 29, 2014
Sales and Marketing Actos, Takeda, bladder cancer, diabetes, lilly

A judge has dramatically reduced the $9 billion damages bill Takeda and Lilly were set to pay over safety allegations …

The Gateway to Local Adoption Series

Latest content